The Magazine of Corporate Responsibility

Tag Archive for ‘Drug Prices’

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.